EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients-Reference-Cited by-同舟云学术

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients

Published:2007-03 Issue:2 Volume:173 Page:107-113
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Bae Nack Cheon,Chae Myung Hwa,Lee Myung Hoon,Kim Kyung Mee,Lee Eung Bae,Kim Chang Ho,Park Tae-In,Han Sung Beom,Jheon Sanghoon,Jung Tae Hoon,Park Jae Yong

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference25 articles.

1. Untangling the ErbB signaling network;Yarden;Nat Rev Mol Cell Biol,2001

2. Targeting RAS signalling pathways in cancer therapy;Downward;Nat Rev Cancer,2003

3. The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors;Weinstein-Oppenheimer;Pharmacol Ther,2000

4. PI3K-Akt pathway: its functions and alterations in human cancer;Osaki;Apoptosis,2004

5. STAT proteins: from normal control of cellular events to tumorigenesis;Calo;J Cell Physiol,2003

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare compound mutation of EGFR L858R and E709A identified in both solid tumor and liquid biopsy of a lung adenocarcinoma patient;Medical Reports;2024-08

2. Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles;Clinical Lung Cancer;2022-11

3. Culture and multiomic analysis of lung cancer patient-derived pleural effusions revealed distinct druggable molecular types;Scientific Reports;2022-04-15

4. Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients;Cancers;2021-06-03

5. Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan;JTO Clinical and Research Reports;2021-02